A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Roelof Bosch, Rudolf Koopmann et al.|The Lancet|2023

Cited by 508